CVS agrees to pay $315 million to settle DOJ opioid prescription case

WASHINGTON — CVS Pharmacy Inc. and various subsidiaries have agreed to pay $315 million to resolve a Justice Department case alleging it unlawfully dispensed medically unnecessary prescriptions of highly addictive opioids, officials said Tuesday.

The settlement resolves a lawsuit brought in 2024 that accused the healthcare giant of providing massive amounts of opioids and other controlled substances “to fuel its own profits at the expense of public health and safety.”

It’s the latest effort by the federal government to hold accountable companies that officials have alleged helped fuel the U.S. addiction and overdose crisis.

“Today’s settlement is a significant milestone in the Justice Department’s efforts to combat the opioid epidemic by cracking down on pharmacies who unlawfully fulfill prescriptions for controlled substances,” Associate Attorney General Stanley Woodward said in an emailed statement.

CVS said in a statement that its pharmacists were trained “in the safe and appropriate use of all medications” and that it had implemented “best-in-class” programs to help them “make the best decisions on behalf of patients.”

The company said it strongly disagreed with the claims made in the lawsuit and that the settlement admits no wrongdoing.

The company said in 2024 that pharmacists were being held to…

Original source: https://www.nbcnews.com/health